Clinical Trial Update: Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety of the tuberculosis vaccine MVA85A delivered by intramuscular or intradermal injection; the study completed with safety dat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED